足细胞
尼福林
波多辛
诱导多能干细胞
细胞生物学
肾小球基底膜
生物
肾
肾小球
肾小球
肾小球肾炎
内分泌学
胚胎干细胞
蛋白尿
生物化学
基因
作者
Samira Musah,Akiko Mammoto,Thomas C. Ferrante,Sauveur S. F. Jeanty,Mariko Hirano-Kobayashi,Tadanori Mammoto,Kristen Roberts,Seyoon Chung,Richard Novák,M. Ingram,Tohid Fatanat-Didar,Sandeep T. Koshy,James C. Weaver,George M. Church,Donald E. Ingber
标识
DOI:10.1038/s41551-017-0069
摘要
An in vitro model of the human kidney glomerulus - the major site of blood filtration - could facilitate drug discovery and illuminate kidney-disease mechanisms. Microfluidic organ-on-a-chip technology has been used to model the human proximal tubule, yet a kidney-glomerulus-on-a-chip has not been possible because of the lack of functional human podocytes - the cells that regulate selective permeability in the glomerulus. Here, we demonstrate an efficient (> 90%) and chemically defined method for directing the differentiation of human induced pluripotent stem (hiPS) cells into podocytes that express markers of the mature phenotype (nephrin+, WT1+, podocin+, Pax2-) and that exhibit primary and secondary foot processes. We also show that the hiPS-cell-derived podocytes produce glomerular basement-membrane collagen and recapitulate the natural tissue/tissue interface of the glomerulus, as well as the differential clearance of albumin and inulin, when co-cultured with human glomerular endothelial cells in an organ-on-a-chip microfluidic device. The glomerulus-on-a-chip also mimics adriamycin-induced albuminuria and podocyte injury. This in vitro model of human glomerular function with mature human podocytes may facilitate drug development and personalized-medicine applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI